Autologous stem cell transplantation in scleroderma.

Presse Med

Scleroderma clinic, Ospedale G. Pini, University of Milan, department of rheumatology, Milano, Italy.

Published: April 2021


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Patients with severe rapidly progressive systemic sclerosis (SSc) have a poor prognosis. Standard immunosuppressive therapies may have modest effects on stabilizing disease, but they fail to improve overall survival. Hematopoietic stem cell transplant (HSCT) is the first treatment to induce disease-modifying therapeutic benefits in rapidly progressive SSc patients. HSCT in rapidly progressive SSc can induce regression of fibrosis in skin and lung, and increase survival. Initially, HSCT was associated with high treatment-related mortality rates. Improvements in patient screening, a better understanding of the risks associated with different treatment regimens, and centre experience have improved the AHSCT safety profile for patients with scleroderma.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lpm.2021.104065DOI Listing

Publication Analysis

Top Keywords

rapidly progressive
12
stem cell
8
progressive ssc
8
autologous stem
4
cell transplantation
4
transplantation scleroderma
4
scleroderma patients
4
patients severe
4
severe rapidly
4
progressive systemic
4

Similar Publications

Early-stage cancer diagnosis is considered a grand challenge, and even though advanced analytical assays have been established through molecular biology techniques, there are still clinical limitations. For example, low concentration of target biomarkers at early stages of cancer, background values from the healthy cells, individual variation, and factors like DNA mutations, remain the limiting factor in early cancer detection. Volatile organic compound (VOC) biomarkers in exhaled breath are produced during cancer cell metabolism, and therefore may present a promising way to diagnose cancer at the early stage since they can be detected both rapidly and non-invasively.

View Article and Find Full Text PDF

To date, environmental conditions have been enough to act as an effective barrier to prevent non-indigenous species from arriving and establishing in Arctic Canada. However, rapidly changing climatic conditions are creating more suitable habitats for non-indigenous species to potentially establish and become invasive. Concurrently, shipping traffic in parts of Arctic Canada has increased by over 250% since 1990, providing an effective vector for transporting non-indigenous species to the region.

View Article and Find Full Text PDF

Objectives: Patients with connective tissue diseases (CTD) have a high incidence of cardiac involvement, which often presents insidiously and can progress rapidly, making it one of the leading causes of death. Multiparametric cardiovascular magnetic resonance (CMR) provides a comprehensive quantitative evaluation of myocardial injury and is emerging as a valuable tool for detecting cardiac involvement in CTD. This study aims to investigate the correlations between CMR features and serological biomarkers in CTD patients, assess their potential clinical value, and further explore the impact of pre-CMR immunotherapy intensity on CMR-specific parameters, thereby evaluating the role of CMR in the early diagnosis of CTD-related cardiac involvement.

View Article and Find Full Text PDF

The regulation of photoperiod and light intensity significantly affected Agastache rugosa by enhancing growth, modifying flowering dynamics, and promoting the accumulation of key phenolic compounds. Agastache rugosa is a medicinal and aromatic plant valued for its bioactive compounds, which contribute to its application in the flavoring, perfume, and food industries. However, variability in the composition of the bioactive compounds poses challenges for its commercial utilization.

View Article and Find Full Text PDF

Glioblastoma multiforme (GBM) is a rapidly progressing brain malignancy, with its progression closely tied to a hypoxic microenvironment. Hypoxia-inducible factor-1α (HIF-1α) acts as a vital regulator in tumor adaptation to low oxygen levels, and its relationship with the Wnt/β-catenin signaling pathway exerts significant functions in the malignant properties of GBM. In this research, Western blot and qRT-PCR were applied to check β-catenin and HIF-1α expression in GBM.

View Article and Find Full Text PDF